Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.
Saved in:
| Title: | Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study. |
|---|---|
| Authors: | Atas Ipek, Suheda1 (AUTHOR) suhedaatas92@gmail.com, Yaslikaya, Sendag2 (AUTHOR), Kara, Ismail Oguz1,3 (AUTHOR), Koseci, Tolga1,4 (AUTHOR), Bayram, Ertugrul1,5 (AUTHOR), Asarkaya, Esra1,6 (AUTHOR), Asoglu, Hatice1,7 (AUTHOR), Turker, Mehmet3,8 (AUTHOR), Aykut, Abdurrahman1,9 (AUTHOR), Jeral Evinc, Seda4,10 (AUTHOR), Alan, Ozkan4,11 (AUTHOR), Yilmaz, Mehmet Emin5,12 (AUTHOR), Ates, Ozturk5,13 (AUTHOR), Yasar, Hatime Arzu6,14 (AUTHOR), Kayaalp, Mehmet6,15 (AUTHOR), Asik, Esra7,16 (AUTHOR), Yildirim, Atila8,17 (AUTHOR), Bacak, Burcu9,18 (AUTHOR), Baykara, Meltem1,9 (AUTHOR), Yurdatap Koc, Dicle2,10 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p4880. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20770383 |
|---|---|
| DOI: | 10.3390/jcm15134880 |
